Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents
- 1 January 2016
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 108, 415-422
Abstract
No abstract availableKeywords
Funding Information
- King Saud University (PRG-1436-05)
This publication has 23 references indexed in Scilit:
- Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agentsEuropean Journal of Medicinal Chemistry, 2015
- Analogue-based design, synthesis and biological evaluation of 3-substituted-(methylenehydrazono)indolin-2-ones as anticancer agentsEuropean Journal of Medicinal Chemistry, 2014
- 7,7′-Diazaindirubin—A small molecule inhibitor of casein kinase 2 in vitro and in cellsBioorganic & Medicinal Chemistry, 2014
- Identification and synthesis of N′-(2-oxoindolin-3-ylidene)hydrazide derivatives against c-Met kinaseBioorganic & Medicinal Chemistry Letters, 2011
- Synthesis, Activity, and Pharmacophore Development for Isatin-β-thiosemicarbazones with Selective Activity toward Multidrug-Resistant CellsJournal of Medicinal Chemistry, 2009
- From the Insoluble Dye Indirubin towards Highly Active, Soluble CDK2‐InhibitorsChemBioChem, 2005
- Structural Basis for the Synthesis of Indirubins as Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 and Cyclin-Dependent KinasesJournal of Medicinal Chemistry, 2004
- Indirubin and Meisoindigo in the Treatment of Chronic Myelogenous Leukemia in ChinaLeukemia & Lymphoma, 2002
- Indirubins Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's DiseaseJournal of Biological Chemistry, 2001
- Inhibition of tumor angiogenesis by synthetic receptor tyrosine kinase inhibitorsDrug Discovery Today, 2000